Syzygium aromaticum L. (Clove) Extract Regulates Energy Metabolism in Myocytes

다국어 초록 (Multilingual Abstract)

The prevalence of metabolic syndrome and type 2 diabetes is increasing worldwide. Herbs and spices have been used for the treatment of diabetes for centuries in folk medicine. Syzygium aromaticum L. (Clove) extracts (SE) have been shown to perform comparably to insulin by significantly reducing blood glucose levels in animal models; however, the mechanisms are not well understood. We investigated the effects of clove on metabolism in C2C12 myocytes and demonstrated that SE significantly increases glucose consumption. The phosphorylation of AMP-activated protein kinase (AMPK), as well as its substrate, acetyl-CoA carboxylase (ACC) was increased by SE treatment. SE also transcriptionally regulates genes involved in metabolism, including sirtuin 1 (SIRT1) and PPARc coactivator 1a (PGC1a). Nicotinamide, an SIRT1 inhibitor, diminished SE’s effects on glucose consumption. Furthermore, treatment with SE dose-dependently increases muscle glycolysis and mitochondrial spare respiratory capacity. Overall, our study suggests that SE has the potential to increase muscle glycolysis and mitochondria function by activating both AMPK and SIRT1 pathways.

참고문헌 (Reference)

1 Shaw RJ, "The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress" 101 : 3329-3335, 2004

2 Marsin AS, "The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase" 277 : 30778-30783, 2002

3 Jung CH, "Syzygium aromaticum ethanol extract reduces high-fat diet-induced obesity in mice through downregulation of adipogenic and lipogenic gene expression" 4 : 409-414, 2012

4 Yeh GY, "Systematic review of herbs and dietary supplements for glycemic control in diabetes" 26 : 1277-1294, 2003

5 Tu Z, "Subdomain VIII is a specificity-determining region in MEKK1" 278 : 48498-48505, 2003

6 Price Nathan L, "SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function" 15 : 675-690, 2012

7 Sun C, "SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B" 6 : 307-319, 2007

8 Tu Z, "Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 Cells" 61 : 2803-2810, 2013

9 Zhou G, "Role of AMP-activated protein kinase in mechanism of metformin action" 108 : 1167-1174, 2001

10 Lagouge M, "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha" 127 : 1109-1122, 2006

11 Marsin AS, "Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia" 10 : 1247-1255, 2000

12 Austin S, "PGC1a and mitochondrial metabolism–emerging concepts and relevance in ageing and neurodegenerative disorders" 125 : 4963-4971, 2012

13 Centers for Disease Control, "National diabetes fact sheet, national estimates and general information on diabetes and prediabetes in the United States" U.S. Department of Health and Human Services, Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2011

14 Kirpichnikov D, "Metformin, An Update" 137 : 25-33, 2002

15 Caton PW, "Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5" 205 : 97-106, 2010

16 Kim YD, "Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP" 57 : 306-314, 2008

17 Rahman S, "Mammalian Sirt1, insights on its biological functions" 9 : 11-, 2011

18 Ruderman NB, "Malonyl-CoA, fuel sensing, and insulin resistance" 276 : E1-E18, 1999

19 Lizcano JM, "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1" 23 : 833-843, 2004

20 Prabhakar PK, "Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes" 18 : 285-291, 2011

21 Tu Z, "IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression" 281 : 6699-6706, 2006

22 Kuroda M, "Hypoglycemic effects of clove(Syzygium aromaticum flower buds)on genetically diabetic KK-Ay mice and identification of the active ingredients" 66 : 394-399, 2012

23 McCloud TG, "High throughput extraction of plant, marine and fungal specimens for preservation of biologically active molecules" 15 : 4526-4563, 2010

24 Purushotham A, "Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation" 9 : 327-338, 2009

25 Raghavan S, "Handbook of Spices, Seasonings, and Flavorings" CRC Press 2007

26 Tennen RI, "Finding a target for resveratrol" 148 : 387-389, 2012

27 Stephanie Jew, "Evolution of the Human Diet: Linking Our Ancestral Diet to Modern Functional Foods as a Means of Chronic Disease Prevention" 한국식품영양과학회 12 (12): 925-934, 2009

28 Bahadoran Z, "Dietary polyphenols as potential nutraceuticals in management of diabetes, a review" 12 : 43-, 2013

29 American Diabetes Association, "Diagnosis and classification of diabetes mellitus" 33 : S62-S69, 2010

30 Ha J, "Critical phosphorylation sites for acetyl-CoA carboxylase activity" 269 : 22162-22168, 1994

31 Viswakarma N, "Coactivators in PPARregulated gene expression" 2010 : 250126-, 2010

32 Karmakar S, "Clove(Syzygium aromaticum Linn)extract rich in eugenol and eugenol derivatives shows bone-preserving efficacy" 26 : 500-509, 2012

33 Nassar MI, "Chemical constituents of clove (Syzygium aromaticum, Fam. Myrtaceae) and their antioxidant activity" 35 : 47-57, 2007

34 Hawley SA, "Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase" 271 : 27879-27887, 1996

35 Peeters A, "Carbohydrate metabolism is perturbed in peroxisome-deficient hepatocytes due to mitochondrial dysfunction, AMP-activated protein kinase (AMPK)activation, and peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) suppression" 286 : 42162-42179, 2011

36 Cefalu WT, "Botanicals and the metabolic syndrome" 87 : 481S-487S, 2008

37 Prasad RC, "An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes" 96 : 295-301, 2005

38 Zhang BB, "An emerging drug target for diabetes and the metabolic syndrome" 9 : 407-416, 2009

39 Srinivasan S, "Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats" 385 : 159-168, 2014

40 Canto C, "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity" 458 : 1056-1060, 2009

41 Steinberg GR, "AMPK in health and disease" 89 : 1025-1078, 2009

42 Ruderman NB, "AMPK and SIRT1, a long-standing partnership?" 298 : E751-E760, 2010

43 Viollet B, "AMP-activated protein kinase in the regulation of hepatic energy metabolism, from physiology to therapeutic perspectives" 196 : 81-98, 2009

44 Singh S, "A database for anti-diabetic plants with clinical/experimental trials" 4 : 263-268, 2009

45 Corton JM, "5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?" 229 : 558-565, 1995